4-[6-[2-[(2,2-dimethylpropanoylamino)methyl]-4-methyl-1,3-thiazol-5-yl]-2-pyridinyl]-5-fluoro-2-hydroxybenzoic acid
C22H22FN3O4S — CID 162757135
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[6-[2-[(2,2-dimethylpropanoylamino)methyl]-4-methyl-1,3-thiazol-5-yl]-2-pyridinyl]-5-fluoro-2-hydroxybenzoic acid
4-[6-[2-[(2,2-dimethylpropanoylamino)methyl]-4-methyl-1,3-thiazol-5-yl]-2-pyridinyl]-5-fluoro-2-hydroxybenzoic acid (PubChem CID 162757135) has the molecular formula C22H22FN3O4S and a molecular weight of 443.50 g/mol. Its IUPAC name is 4-[6-[2-[(2,2-dimethylpropanoylamino)methyl]-4-methyl-1,3-thiazol-5-yl]-2-pyridinyl]-5-fluoro-2-hydroxybenzoic acid.
Molecular Properties
| Compound Name | 4-[6-[2-[(2,2-dimethylpropanoylamino)methyl]-4-methyl-1,3-thiazol-5-yl]-2-pyridinyl]-5-fluoro-2-hydroxybenzoic acid |
|---|---|
| PubChem CID | 162757135 |
| Molecular Formula | C22H22FN3O4S |
| Molecular Weight | 443.50 g/mol |
| Exact Mass | 443.13 |
| IUPAC Name | 4-[6-[2-[(2,2-dimethylpropanoylamino)methyl]-4-methyl-1,3-thiazol-5-yl]-2-pyridinyl]-5-fluoro-2-hydroxybenzoic acid |
| SMILES | Cc1nc(CNC(=O)C(C)(C)C)sc1-c1cccc(-c2cc(O)c(C(=O)O)cc2F)n1 |
| InChI | InChI=1S/C22H22FN3O4S/c1-11-19(31-18(25-11)10-24-21(30)22(2,3)4)16-7-5-6-15(26-16)12-9-17(27)13(20(28)29)8-14(12)23/h5-9,27H,10H2,1-4H3,(H,24,30)(H,28,29) |
| InChIKey | UPNXGJFPOWIFAM-UHFFFAOYSA-N |
| XLogP | 4.39 |
| TPSA | 112.41 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 443.50 |
| LogP ≤ 5 | 4.39 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162757135 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.